Summit Wealth Group’s Boston Scientific BSX Stock Holding History

Summit Wealth Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,514	Closed	–	–	99
2023 Q1	$0	Buy	+23,514	New	+$1.11M	﹤0.01%	166

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Summit Wealth Group's BSX Position: Q2 2023 in Review

Summit Wealth Group sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 23,514 shares.

Summit Wealth Group first reported a position in BSX in Q1 2023 and held it in 1 quarter. The position peaked at $0 in Q1 2023. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

Summit Wealth Group reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
Summit Wealth Group sold 23,514 Boston Scientific shares in Q2 2023.
Summit Wealth Group first reported a position in Boston Scientific in Q1 2023 and held it in 1 quarter.
Summit Wealth Group's Boston Scientific position peaked at $0 in Q1 2023.
1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Summit Wealth Group's 13F filing for Q2 2023, filed 26 Jul 2023.